ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$11.32
+0.32 (+2.91%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
-52.8% upside
Low Target
$3.67
Average Target
$5.34
High Target
$6.76
Current Price
$11.32
Current
$11.32
$11.32
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Scenario Analysis
Bear Case
$3.67
-67.6%
Low target
Base Case
$5.34
-52.8%
Avg target
Bull Case
$6.76
+-40.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$13.16
-14.0% from high
52-Week Low
$7.16
+58.1% from low
Target vs 52W High
$5.34
-59.4% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $0.08
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals